Identification of novel topoisomerase II alpha inhibitors by virtual screening, molecular docking, and bioassay-Reference-Cited by-同舟云学术

Identification of novel topoisomerase II alpha inhibitors by virtual screening, molecular docking, and bioassay

Published:2021-08-15 Issue:1 Volume:99 Page:92-102
ISSN:1747-0277
Container-title:Chemical Biology & Drug Design
language:en
Short-container-title:Chem Biol Drug Des

Author:

Yu Che¹,Hu Jiabao²,Luyten Walter³,Sun Dan³⁴,Jiang Tao⁵

Affiliation:

1. Department of Nephrology Shandong Provincial Hospital Affiliated to Shandong First Medical University Jinan China

2. School of Pharmacy China Pharmaceutical University Nanjing China

3. Animal Physiology and Neurobiology Section Department of Biology KU Leuven Leuven Belgium

4. College of Life Sciences Nankai University Tianjin China

5. Department of Anesthesiology Shandong Cancer Hospital and Institute Shandong First Medical University and Shandong Academy of Medical Sciences Jinan China

Funder

China Scholarship Council

Publisher

Wiley

Subject

Molecular Medicine,Biochemistry,Drug Discovery,Pharmacology,Organic Chemistry

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cbdd.13927

Reference60 articles.

1. Virtual screening of potential inhibitors from TCM for the CPSF30 binding site on the NS1A protein of influenza A virus

2. Pharmacophore mapping-based virtual screening followed by molecular docking studies in search of potential acetylcholinesterase inhibitors as anti-Alzheimer's agents

3. Roles of DNA topoisomerase II isozymes in chemotherapy and secondary malignancies

4. Contemporary Challenges in the Design of Topoisomerase II Inhibitors for Cancer Chemotherapy

5. In vitro assays used to measure the activity of topoisomerases

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Design and in silico Prediction of New Methylenedioxyphenyl Derivatives as DNA Topoisomerase II Inhibitors;International Journal of Pharmaceutical Investigation;2023-07-08

2. Imidazo[4,5-b]phenazines as Dual Topoisomerase I/IIα Inhibitors: Design, Synthesis, Biological Evaluation and Molecular Docking;Egyptian Journal of Chemistry;2022-10-09